Bausch Health Companies BHC
NYSE BHC
$5.81 +0.17 (+3.02%)
As of: Sep 22, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Income from Continuing Operations (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Income from Continuing Operations came in at $260.0 million in Q2 2026, up 103.12% year-over-year from $128.0 million in Q2 2025, and up 118.17% quarter-over-quarter from -$1.4 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Income from Continuing Operations across 18 years of filings, most recently posting $260.0 million for Q2 2026.

  • In Q2 2026, Income from Continuing Operations rose 103.12% year-over-year to $260.0 million; the TTM figure through Jun 2026 stood at -$1.1 billion (down 2377.08% YoY), while the FY2025 annual figure was $120.0 million, up 266.67% from the prior year.
  • Income from Continuing Operations came in at $260.0 million for Q2 2026 at Bausch Health Companies, up from -$1.4 billion in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
  • Average Income from Continuing Operations over 5 years is -$108.1 million, with a median of -$71.5 million recorded in 2022.
  • Year-over-year, Income from Continuing Operations jumped 12900.0% in 2025 and sank 1563.95% in 2026.
  • Over 5 years, Income from Continuing Operations stood at -$410.0 million in 2022, then soared by 88.54% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then tumbled by 205.1% to -$103.0 million in 2025, then soared by 352.43% to $260.0 million in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were $260.0 million in Q2 2026, -$1.4 billion in Q1 2026, and -$103.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn -576.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn -118.80 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 45.93 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 69.61 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 260.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 24.70 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -66.70 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 30.35 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 1.97 Mn
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 -880,561.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 260.00 Mn
Mar 31, 2026 -1.43 Bn
Dec 31, 2025 -103.00 Mn
Sep 30, 2025 181.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 -92.00 Mn
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 -77.00 Mn
Dec 31, 2023 -47.00 Mn
Sep 30, 2023 -382.00 Mn
Jun 30, 2023 27.00 Mn
Mar 31, 2023 -209.00 Mn
Dec 31, 2022 -410.00 Mn
Sep 30, 2022 403.00 Mn
Jun 30, 2022 -139.00 Mn
Mar 31, 2022 -66.00 Mn
Dec 31, 2021 72.00 Mn
Sep 30, 2021 191.00 Mn
API Access

Bausch Health Companies Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BHC&period=max&api_key=YOUR_API_KEY